Page last updated: 2024-10-22

theophylline and Carcinoma, Ovarian Epithelial

theophylline has been researched along with Carcinoma, Ovarian Epithelial in 1 studies

Carcinoma, Ovarian Epithelial: A malignant neoplasm that originates in cells on the surface EPITHELIUM of the ovary and is the most common form of ovarian cancer. There are five histologic subtypes: papillary serous, endometrioid, mucinous, clear cell, and transitional cell. Mutations in BRCA1, OPCML, PRKN, PIK3CA, AKT1, CTNNB1, RRAS2, and CDH1 genes are associated with this cancer.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Liu, L1
Cai, S1
Han, C1
Banerjee, A1
Wu, D1
Cui, T1
Xie, G1
Zhang, J1
Zhang, X1
McLaughlin, E1
Yin, M1
Backes, FJ1
Chakravarti, A1
Zheng, Y1
Wang, QE1

Other Studies

1 other study available for theophylline and Carcinoma, Ovarian Epithelial

ArticleYear
ALDH1A1 Contributes to PARP Inhibitor Resistance via Enhancing DNA Repair in BRCA2
    Molecular cancer therapeutics, 2020, Volume: 19, Issue:1

    Topics: Aldehyde Dehydrogenase 1 Family; Animals; Antineoplastic Combined Chemotherapy Protocols; BRCA1 Prot

2020